Scarica l'app Stockscreener
27.13
3.87%
1.01
Precedente Chiudi:
$26.12
Aprire:
$26.12
Volume 24 ore:
1.71M
Relative Volume:
1.09
Capitalizzazione di mercato:
$1.53B
Reddito:
$308.05M
Utile/perdita netta:
$-95.57M
Rapporto P/E:
-15.77
EPS:
-1.72
Flusso di cassa netto:
$-58.34M
1 W Prestazione:
+12.01%
1M Prestazione:
-2.37%
6M Prestazione:
-26.95%
1 anno Prestazione:
-51.58%
Intervallo 1D:
$26.00
$27.39
Intervallo di 1 settimana:
$23.31
$27.87
Portata 52W:
$19.35
$66.85
Procept Biorobotics Corp Stock (PRCT) Company Profile
Nome
Procept Biorobotics Corp
Settore
Industria
Telefono
(650) 232-9832
Indirizzo
150 BAYTECH DRIVE, SAN JOSE
Compare PRCT vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PRCT
Procept Biorobotics Corp
|
27.13 | 1.53B | 308.05M | -95.57M | -58.34M | -1.72 |
|
ABT
Abbott Laboratories
|
108.03 | 187.72B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
336.77 | 128.88B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
87.14 | 111.88B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.13 | 102.58B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
81.81 | 47.52B | 6.07B | 1.06B | 1.34B | 1.8063 |
Procept Biorobotics Corp Stock (PRCT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-06 | Iniziato | Robert W. Baird | Neutral |
| 2026-02-26 | Downgrade | BofA Securities | Neutral → Underperform |
| 2026-02-26 | Downgrade | Oppenheimer | Outperform → Perform |
| 2025-12-12 | Iniziato | UBS | Buy |
| 2025-12-08 | Downgrade | BofA Securities | Buy → Neutral |
| 2025-09-02 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2025-07-09 | Iniziato | Stephens | Overweight |
| 2025-07-07 | Iniziato | Oppenheimer | Perform |
| 2024-12-02 | Iniziato | Morgan Stanley | Overweight |
| 2024-11-14 | Iniziato | Jefferies | Hold |
| 2023-08-11 | Iniziato | Piper Sandler | Overweight |
| 2023-05-31 | Iniziato | William Blair | Outperform |
| 2022-10-31 | Iniziato | BTIG Research | Neutral |
| 2022-10-25 | Iniziato | Truist | Buy |
| 2022-09-02 | Iniziato | Wells Fargo | Overweight |
| 2022-07-15 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2022-06-23 | Iniziato | B. Riley Securities | Buy |
| 2021-10-11 | Iniziato | BofA Securities | Buy |
| 2021-10-11 | Iniziato | Cowen | Outperform |
| 2021-10-11 | Iniziato | Goldman | Neutral |
| 2021-10-11 | Iniziato | Guggenheim | Buy |
| 2021-10-11 | Iniziato | SVB Leerink | Outperform |
Mostra tutto
Procept Biorobotics Corp Borsa (PRCT) Ultime notizie
ArrowMark Colorado Holdings LLC Raises Stake in PROCEPT BioRobotics Corporation $PRCT - MarketBeat
Assessing PROCEPT BioRobotics (PRCT) Valuation After HYDROS Robotic System Expansion News - simplywall.st
Thematics Asset Management Raises Stock Position in PROCEPT BioRobotics Corporation $PRCT - MarketBeat
Prosight Management LP Takes $2.75 Million Position in PROCEPT BioRobotics Corporation $PRCT - MarketBeat
PROCEPT BioRobotics Corp (PRCT) Trading 4.31% Higher on Mar 13 - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against PROCEPT BioRobotics Corporation (PRCT) And Encourages Investors to Reach Out - ACCESS Newswire
2026-03-13 | Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against PROCEPT BioRobotics Corporation (PRCT) And Encourages Investors to Reach Out | NDAQ:PRCT | Press Release - Stockhouse
Mackenzie Financial Corp Raises Stock Position in PROCEPT BioRobotics Corporation $PRCT - MarketBeat
PROCEPT BioRobotics launches HYDROS system in UK By Investing.com - Investing.com India
FMR LLC Reduces Stake in PROCEPT BioRobotics Corp by 65.40% - GuruFocus
PROCEPT BioRobotics launches HYDROS system in UK - Investing.com South Africa
Insider Selling: PROCEPT BioRobotics (NASDAQ:PRCT) EVP Sells 3,243 Shares of Stock - MarketBeat
Procept BioRobotics announces international Hydros robot launch - MassDevice
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against PROCEPT BioRobotics Corporation (PRCT) And Encourages Stockholders to Reach Out - ACCESS Newswire
Procept BioRobotics announce international launch of HYDROS Robotic - TipRanks
PROCEPT BioRobotics® Announces International Launch of the HYDROS® Robotic System, Expanding Global Access to AI-Enabled Aquablation® Therapy - The Manila Times
PROCEPT BioRobotics Overcomes S-Curve Challenge as HYDROS Seeks Rapid Expansion of BPH Treatments - Bitget
PROCEPT BioRobotics (NASDAQ:PRCT) Trading Up 7.2%Time to Buy? - MarketBeat
PRCT: $50.2M ADJUSTED EBITDA LOSS VS. $35M PROJECTED -- LEVI & KORSINSKY, LLP INVESTIGATES - marketscreener.com
PROCEPT BioRobotics Corporation (PRCT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Pomerantz Law Firm Investigates Claims On Behalf of Investors of PROCEPT BioRobotics CorporationPRCT - FinancialContent
[144] PROCEPT BioRobotics Corp SEC Filing - Stock Titan
Securities Fraud Investigation Into PROCEPT BioRobotics Corporation (PRCT) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm - The AI Journal
Securities Fraud Investigation Into PROCEPT BioRobotics Corporation (PRCT) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm - Benzinga
PROCEPT BioRobotics (NASDAQ:PRCT) Shares Gap Up on Insider Buying Activity - MarketBeat
Is PROCEPT’s Growth Targets And New CFO Director Altering The Investment Case For PROCEPT BioRobotics (PRCT)? - simplywall.st
Major Insider Shake-Up at PROCEPT BioRobotics as Top Executives Trade Shares - TipRanks
Procept Biorobotics director Desai buys PRCT shares worth $10.4m By Investing.com - Investing.com Nigeria
Procept Biorobotics director Desai buys PRCT shares worth $10.4m - Investing.com
Securities Fraud Investigation Into PROCEPT BioRobotics Corporation (PRCT) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz - The AI Journal
PROCEPT BioRobotics (NASDAQ:PRCT) Director Antal Rohit Desai Purchases 167,246 Shares - MarketBeat
PROCEPT BioRobotics (NASDAQ:PRCT) Director Buys $3,781,878.03 in Stock - MarketBeat
Insider Buying: PROCEPT BioRobotics (NASDAQ:PRCT) Director Acquires 98,699 Shares of Stock - MarketBeat
Kevin Waters Sells 6,721 Shares of PROCEPT BioRobotics (NASDAQ:PRCT) Stock - MarketBeat
PROCEPT BioRobotics (NASDAQ:PRCT) EVP Sells $163,340.40 in Stock - MarketBeat
Procept BioRobotics appoints Daniel Puckett to board and audit committee By Investing.com - Investing.com Nigeria
Alaleh Nouri, EVP at Procept Biorobotics, sells $163k in shares - Investing.com
PROCEPT BioRobotics (PRCT) CFO nets equity grants, sells shares for taxes - Stock Titan
Dan Puckett joins PROCEPT BioRobotics (PRCT) board in Form 3 filing - Stock Titan
PRCT Investors Have Opportunity to Join PROCEPT BioRobotics Corporation Fraud Investigation with the Schall Law Firm - Business Wire
PROCEPT BioRobotics Corporation $PRCT Shares Purchased by Rhenman & Partners Asset Management AB - MarketBeat
Blair William & Co. IL Purchases 169,237 Shares of PROCEPT BioRobotics Corporation $PRCT - MarketBeat
PROCEPT BioRobotics Adds Independent Director to Audit Committee - The Globe and Mail
Baird Initiates Coverage of PROCEPT BioRobotics (PRCT) with Neutral Recommendation - Nasdaq
Baird initiates Procept BioRobotics stock rating at Neutral By Investing.com - Investing.com India
PROCEPT BioRobotics (NASDAQ:PRCT) Shares Down 6.9%Time to Sell? - MarketBeat
FMR LLC Holds 1.61M Shares of Procept Biorobotics (NASDAQ: PRCT) - Stock Titan
Baird initiates Procept BioRobotics stock rating at Neutral - Investing.com
Robert W. Baird Initiates Coverage on PROCEPT BioRobotics (NASDAQ:PRCT) - MarketBeat
Procept Biorobotics Corporation Appoints Daniel Puckett Board and Audit Committee Member, Effective March 5, 2026 - marketscreener.com
PRCT: Baird Initiates Neutral Rating with $30 Price Target | PRC - GuruFocus
Procept Biorobotics Corp Azioni (PRCT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.66%
1.56%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):